Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib. - Svanberg R; Ostrowski SR; Nasserinejad K; Kersting S; Dobber JA; Mattson M; Tran HTT; Levin MD; Mous R; Kater AP; Niemann CU (Leukemia & lymphoma, 2020)